CFMS - ConforMIS, Inc.

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。

ConforMIS, Inc.

600 Technology Park Drive
Billerica, MA 01821
United States

行業Medical Instruments & Supplies


Mr. Mark A. AugustiChief Exec. Officer, Pres and Director279.31k1966
Dr. Philipp Lang M.D., MBAFounder & Director1.41M1963
Mr. Paul S. Weiner CPAChief Financial Officer341.83k1964
Dr. Daniel Steines M.D., MSChief Technology Officer304.88k1969
Mr. David Cerveny J.D.Chief Legal Officer, Gen. Counsel and Sec.1967
截止 2016年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。


ConforMIS, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides ConforMIS Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, and Monaco. ConforMIS, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.


截至 2018年3月1日 止,ConforMIS, Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中:2;董事會:9;股東權利:8;現金賠償:9。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。